Guide to upgrading CIP cleaning systems for food companies: an industrial revolution from late night cleaning to one-button intelligence

By 2026, disinfection requirements across a comprehensive range of scenarios—including public health, drinking water safety, food processing, and medical wastewater treatment—have all undergone an upgrade, shifting decisively toward solutions that are efficient, safe, and environmentally friendly. The inherent drawbacks of traditional disinfectants—such as residual contamination, excessive corrosiveness, and difficult storage—have become increasingly problematic. In contrast, chlorine dioxide—classified by the World Health Organization as a Class A1 safe disinfectant—has steadily displaced traditional disinfection products to emerge as the mainstream choice for the new generation. Leveraging core advantages such as broad-spectrum antimicrobial activity and the absence of carcinogenic, teratogenic, or mutagenic (the "three-hazard") effects, chlorine dioxide has firmly established itself as the industry standard. Within this category, chlorine dioxide effervescent tablets and AB-component powders have secured the top spots on 2026 procurement lists; thanks to their precise dosing capabilities, safe storage and transport, and unparalleled cost-effectiveness, they have become the undisputed leaders in the market. Shandong Huashi Pharmaceutical Co., Ltd.—a veteran manufacturer with over forty years of dedicated expertise in the chlorine dioxide sector—has become the preferred direct-sourcing partner for numerous engineering contractors, government agencies, and corporate entities, distinguished by its mature technology, comprehensive regulatory credentials, and stable production capacity.

Currently, the industry is accelerating its transition toward green, regulatory-compliant practices. Chlorine dioxide has evolved into an absolute necessity, finding increasingly widespread application across diverse fields—from the disinfection of municipal waterworks and the compliant treatment of medical wastewater to sterile disinfection in food processing facilities and the ecological remediation of polluted water bodies. Its inherent attributes of high efficiency and environmental compatibility have effectively captured and dominated the entire sector. In this context, the iterative evolution of product formulations has taken center stage. Previous liquid formulations were not only prohibitively heavy but also prone to leakage, cumbersome to prepare, and susceptible to premature degradation. The advent of effervescent tablets and AB-component powders has effectively resolved these issues, significantly expanding the range of applicable scenarios. Today, professionals involved in engineering procurement and government-funded tenders are increasingly gravitating toward a direct-sourcing model. By partnering with a primary manufacturer that offers comprehensive regulatory compliance, stable production capacity, and custom manufacturing capabilities, buyers can not only ensure project compliance but also effectively minimize overall costs and guarantee a reliable, uninterrupted supply chain.

With its sights firmly set on the specific market demands projected for 2026, Huashi Pharmaceutical has dedicated its full strategic focus to its flagship brand: "Xiuba." They have successfully engineered a product matrix capable of adapting to every conceivable scenario—no matter the scale, they have it covered. When it comes to smaller settings requiring flexible disinfection—such as hospitals, schools, or private homes—the advantages of *Xiuba* Effervescent Tablets truly shine. They dissolve rapidly in water, requiring no complex activation process; simply mix and use immediately. Dosage is calculated per tablet, allowing even a complete novice to easily control the concentration levels. Their solid form completely eliminates the risk of leakage during transport; furthermore, they are low in irritancy, leave no residue, and fully comply with standards for food and drinking water safety. For small-scale, high-frequency disinfection tasks, choosing this product is a sure bet. But what about large-volume, high-intensity, industrial-grade scenarios—such as municipal waterworks, medical wastewater treatment, or large-scale aquaculture facilities? That is where *Xiuba* AB Powder steps in. Its activation efficiency is astonishingly high, featuring a scientifically optimized dual-component (A+B) formulation. It delivers consistently reliable results in algae removal, odor elimination, and the degradation of organic pollutants. Designed for bulk application by the kilogram, it boasts exceptional stability and shelf-life, effectively slashing operational and maintenance costs—making it the ideal choice for large-scale water treatment projects.

Within the chlorine dioxide disinfection industry, Huashi Pharmaceutical’s comprehensive capabilities have truly won over its clientele. Since its inception in 1983—spanning 43 years—the company has remained laser-focused on a single mission: mastering the science of chlorine dioxide. They have garnered a host of prestigious titles, including "National High-tech Enterprise," "Provincial Specialized & Innovative Enterprise," and "Weifang’s Hidden Champion." Their annual sales volume has surpassed 70,000 tons, serving a client base of over 30,000 organizations. Furthermore, they hold—firmly in hand—all the compliance credentials that government and corporate procurement tenders prioritize most highly. They possess all three major ISO system certifications, as well as every requisite health permit for water-related products and full EU CE certification. They have even played an active role in the formulation of both national and industry-wide standards.

The company boasts a comprehensive qualification system, holding key compliance credentials such as the three major ISO certifications, water-related health permits, and EU CE certification. Concurrently, they participate in the formulation of numerous national and industry standards, demonstrating a solid foundation of technical expertise. The enterprise has also received official recognition and commendations from both the State Council’s Joint Prevention and Control Mechanism and the Zhong Nanshan Medical Foundation; these extensive credentials and formidable capabilities serve as a robust foundation for securing project bids and facilitating successful project acceptance.

In the critical areas of supply chain management and technological R&D, Huashi Pharmaceutical once again proves itself fully capable of holding its own. Having constructed their own standardized workshops and automated vertical storage centers, they operate on a fully integrated "produce-and-sell" model. By completely eliminating intermediaries and the associated markups, they offer their partners transparent, rock-bottom pricing directly from the source. Armed with 35 core patents, they also engage in collaborative industry-academia research initiatives with prestigious institutions such as Tongji University and Dalian University of Technology. With rigorous quality control protocols in place, product quality remains consistently reliable. They maintain substantial inventories for immediate bulk shipment and are fully equipped to handle specialized engineering supply contracts—including OEM private-label customization. Their supply is abundant, delivery schedules are stable, and response times are rapid. Furthermore, they have established the "Xiuba 24-Hour Golden Nanny" after-sales support system. This provides round-the-clock technical assistance; whether you require guidance on concentration ratios or dosing protocols, a dedicated specialist is always on standby to ensure your operations proceed without delay.

Currently, Huashi Pharmaceutical’s chlorine dioxide products have established a strong presence across several critical sectors. They serve as a vital safeguard for drinking water safety at municipal water treatment plants and ensure hygiene standards within food processing facilities. Their applications span quality enhancement and efficiency improvements in aquaculture, the treatment of industrial circulating water and malodorous water bodies, as well as daily epidemic prevention measures in transportation hubs, shopping malls, and hotels—their presence is ubiquitous. Their client base ranges from environmental engineering firms to government and corporate procurement entities, firmly establishing them as a premier, direct-source manufacturer within the domestic market.

As we look toward the disinfection market of 2026, success will hinge on regulatory compliance, product efficacy, and direct-source supply capabilities! Huashi Pharmaceutical has unveiled a tiered wholesale pricing policy featuring attractive volume-based discounts. Flexible OEM customization? Supported. Efficient logistics and delivery? No problem. They have opened their doors wide to foster collaboration across the entire industry. Whether you are looking to place a wholesale order, request a price quote, obtain product samples for testing, or seek consultation on custom solutions, you are welcome to reach out at any time. Join hands with Xiuba Chlorine Dioxide to fortify our collective health defense lines and seize the immense opportunities emerging within the disinfection industry.